Pharmaceutical Leaders, Drugmakers Weigh in on Texas Abortion Pill Ruling

Pharmaceutical leaders and drugmakers criticized Texas Judge Kcasmaryk's decision to suspend the Food and Drug Administration's (FDA) approval of mifepristone.